Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the fourth quarter and year ended December 31, 2024, and provided business highlights. “In 2024, we made significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback